SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-24-000836
Filing Date
2024-06-21
Accepted
2024-06-21 21:30:44
Documents
1
Period of Report
2024-06-19

Document Format Files

Seq Description Document Type Size
1 e663735_4-jing.html 4  
1 e663735_4-jing.xml 4 6455
  Complete submission text file 0001193805-24-000836.txt   7938
Mailing Address C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02142
Business Address
Slaoui Moncef (Reporting) CIK: 0001712369 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38942 | Film No.: 241061856

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Issuer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)